- 全部删除
您的购物车当前为空
AS-604850 is a selective and ATP-competitive PI3Kγ inhibitor (IC50= 2.5 μM). It has over 30-fold selectivity for PI3Kδ and PI3Kβ, and 18-fold selectivity over PI3Kα.

AS-604850 is a selective and ATP-competitive PI3Kγ inhibitor (IC50= 2.5 μM). It has over 30-fold selectivity for PI3Kδ and PI3Kβ, and 18-fold selectivity over PI3Kα.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 2,175 | 3-6月 | |
| 10 mg | ¥ 3,831 | 3-6月 | |
| 25 mg | ¥ 8,349 | 3-6月 |
AS-604850 相关产品
| 产品描述 | AS-604850 is a selective and ATP-competitive PI3Kγ inhibitor (IC50= 2.5 μM). It has over 30-fold selectivity for PI3Kδ and PI3Kβ, and 18-fold selectivity over PI3Kα. |
| 靶点活性 | PI3Kγ:0.18 μM (Ki), PI3Kγ:0.25 μM, PI3Kα:4.5 μM |
| 体外活性 | AS-604850 pretreatment abolished GCDC-induced phosphorylation of Akt by 50% and inhibited apoptosis by reducing GCDC/TCDC/TLC-induced caspase-3 cleavage in rat hepatocytes. In PI3KCG-/-monocytes and THP-1 (human monocytic cell line), AS-604850 inhibited the PKB phosphorylation activated by MCP-1, it also blocked the MCP-1-mediated chemotaxis in a concentration-dependent manner. In RAW264 mouse macrophages, C5a-mediated PKB phosphorylation was inhibited by AS-604850 [1][2]. |
| 体内活性 | In the thioglycollate-induced peritonitis model that induced multiple chemokines in vivo, oral administration of 10 mg/kg AS-604850 showed a 31% decrease in neutrophil recruitment [1]. |
| 分子量 | 285.22 |
| 分子式 | C11H5F2NO4S |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: Soluble |
评论内容